and the paving plate was resuspended by adding matrix glue (abs9495) at 25 times the tissue volume
with C-terminal 8*His ASCREVCCPVGPSGLRCTRAGSLDTLRGLRGAGNLTELYVENQQHLQRLEFEDLQGLGELRSLTIVKSGLRFVAPDAFRFTPRLSHLNLSSNALESLSWKTVQGLSLQDLTLSGNPLHCSCALFWLQRWEQEGLCGVHTQTLHDSGPGDQFLPLGHNTSCGVPTVKIQMPNDSVEVGDDVFLQCQVEGLALQQADWILTELEGAATVKKFGDLPSLGLILVNVTSDLNKKNVTCWAENDVGRAEVSVQVSVSFPASVHLGLAVEQHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTQFLESALTNETMRHGCLRLNQPTHVNNGNYTLLAANPYGQAAASVMAAFMDNPFEFNPEDPIPVSFSPVDGNSTSRDPVEKKDETPFGGGGSHHHHHHHH
(2006) Human MICL (CLEC12A) is differentially glycosylated and is down-regulated following cellular activation
Recovery rate: Different levels of Human EGF were spiked into cell culture medium samples and the recovery rate was determined
280(21): 20509-15
p21 Waf1/Cip1 Mouse mAb (469-2) Size:25μl and the paving plate wasProduct Specification Host Mouse Antigen p21 Waf1 Cip1 Synonyms WAFT, Cyclin dependent kinase inhibitor 1, CDK interacting protein 1, MDA 6, p21, CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1 Immunogen Synthetic Peptide Location Nucleus Accession P38936 Clone Number 469 2 Antibody Type Mouse mAb Isotype IgG2a Application WB, IHC P, ICC, ICFCM Reactivity Hu Purification Protein A Concentration 2 mg ml Conjugation Unconjugated Physical Appearance Liquid